Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Mortality in Crohn's disease

P Prior, S Gyde, W T Cooke

    Gastroenterology
    |February 1, 1981
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Antimicrobial Activity of the Quinoline Derivative HT61 against Staphylococcus aureus Biofilms.

    Antimicrobial agents and chemotherapy·2020
    Same author

    Immunological profiling of key inflammatory drivers of nasal polyp formation and growth in chronic rhinosinusitis.

    Rhinology·2019
    Same author

    A New Type of Strain of Xanthomonas euvesicatoria Causing Bacterial Spot of Tomato and Pepper in Grenada.

    Plant disease·2019
    Same author

    SU-E-T-252: Consolidating Duodenal/Small Bowel Toxicity Data via Iso-Effective Dose Calculations Based on Compiled Clinical Data.

    Medical physics·2017
    Same author

    Invasive Propionibacterium acnes infections in a non-selective patient cohort: clinical manifestations, management and outcome.

    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·2014
    Same author

    Genetic mapping of a major dominant gene for resistance to Ralstonia solanacearum in eggplant.

    TAG. Theoretical and applied genetics. Theoretische und angewandte Genetik·2012

    Patients with Crohn's disease face a doubled mortality risk, especially younger individuals soon after diagnosis. This increased risk of death from Crohn's disease complications and other causes declines with age at diagnosis and time since diagnosis.

    Area of Science:

    • Gastroenterology
    • Epidemiology
    • Clinical Medicine

    Background:

    • Crohn's disease is a chronic inflammatory bowel disease with significant long-term health implications.
    • Understanding the long-term mortality risks associated with Crohn's disease is crucial for patient management and public health.
    • Previous studies have indicated potential increased mortality, but comprehensive long-term data are essential.

    Purpose of the Study:

    • To investigate the long-term mortality risk in a large cohort of patients diagnosed with Crohn's disease.
    • To compare the mortality rates of Crohn's disease patients with a matched general population cohort.
    • To identify specific causes of death and factors influencing mortality risk in Crohn's disease.

    Main Methods:

    • A longitudinal study following 513 patients with Crohn's disease for up to 35 years.

    Related Experiment Videos

  • Comparison of observed mortality in the patient cohort against expected mortality in a matched general population.
  • Analysis of mortality data stratified by age at diagnosis, time since diagnosis, sex, and cause of death.

    • Main Results:

    • Crohn's disease patients exhibited a twofold increased risk of mortality (102 observed vs. 51.8 expected; p < 0.001).
    • The highest mortality risk was observed in younger patients shortly after diagnosis, decreasing with age at diagnosis and time since diagnosis.
    • Significant excess deaths were noted from digestive organ tumors (p < 0.05), suicide in women (p < 0.01), and complications directly related to Crohn's disease (p < 0.001).

    Conclusions:

    • Crohn's disease is associated with a substantially increased long-term mortality risk.
    • Mortality risk is most pronounced in early-diagnosed, younger patients and diminishes over time.
    • Management strategies should address not only disease-specific complications but also associated risks like malignancy and suicide.